GlassScriptPhysician profile
Speros Gabriel
NPI 1063094373
$5,421.62
in general payments reported to CMS, 2019-2025
11 companies · $1,204 in 2025
The $1,204 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,200 · 2022: $189 · 2023: $930 · 2024: $1,899 · 2025: $1,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,665 · Education: $280 · Travel and Lodging: $87.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,664.78 |
| Education | $279.99 |
| Travel and Lodging | $87.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,118.31 | 2022-2025 | Blueprint Patient Specific Instrumentation, Mako, Tornier Perform Reversed Augmented Glenoid |
| Titan Surgical Group, LLC | $1,546.29 | 2021-2025 | |
| Medical Device Business Services, INC. | $473.99 | 2024-2025 | Inhance, Attune |
| Zimmer Biomet Holdings, INC. | $293.93 | 2024 | Persona, Comprehensive |
| Linvatec Corporation | $288.59 | 2023 | Biobrace 23mm |
| Depuy Synthes Sales INC. | $265.11 | 2024-2025 | Inhance, Lcp |
| Si-Bone, INC. | $120.87 | 2024 | |
| Innovation Technologies INC | $106.14 | 2023 | Irrisept |
| Bioventus LLC | $105.54 | 2025 | Exogen Ultrasound Bone Healing System |
| Catalyst Orthoscience | $74.98 | 2025 | R1 Reverse Total Shoulder, Catalyst Fracture Shoulder System, Archer Csr Total Shoulder System |
| Avanos Medical | $27.87 | 2025 | On-Q Pump and Accessories |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Speros Gabriel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.